Literature DB >> 17296574

The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor.

Norma Cristina Sousa1, Joyce Maria Anicchino-Bizzacchi, Maria Fátima Locatelli, Vagner Castro, Maria Lourdes Barjas-Castro.   

Abstract

The aim of this study was to correlate ABO groups with plasma levels of factor VIII (FVIII), von Willebrand factor (VWF:Ag), and ristocetin cofactor (VWF:RCo). Serological and molecular tests defined blood groups from 114 donors (10 AA, 10 BB, 10 AB, 10 AO1, 10 BO1,16 O1O1, 20 A2O1, 20 A2B, 4 A3O1, 3 AxO1, and 1 BelO1). The levels of VWF:Ag, FVIII and VWF:RCo observed in rare subgroups (A3O1, AxO1, BelO1) were similar to the values found in the O1O1 group. However, levels of these factors were significantly higher in A2O1 donors than in O1O1 donors (VWF:Ag p=0.01; FVIII p=0.04; VWF:RCo p<0.001). Strong correlations were demonstrated between plasma levels of VWF:Ag and FVIII (R=0.77; p=0.001) and between VWF:Ag and VWF:RCo (R=0.75; p=0.001).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296574     DOI: 10.3324/haematol.10457

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  16 in total

1.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

2.  ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingheti; Danyelle Romana Alves Rios; Luci Maria SantAna Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

3.  The clinical value of von Willebrand factor in colorectal carcinomas.

Authors:  Vera S Schellerer; Larissa Mueller-Bergh; Susanne Merkel; Robert Zimmermann; Dominik Weiss; Anne Schlabrakowski; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Am J Transl Res       Date:  2011-09-23       Impact factor: 4.060

4.  Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer.

Authors:  Xia Liu; Xiaogang Chen; Jiezuan Yang; Renyong Guo
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 5.  Relationship between ABO blood group and pregnancy complications: a systematic literature analysis.

Authors:  Massimo Franchini; Carlo Mengoli; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2016-05-05       Impact factor: 3.443

6.  Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.

Authors:  Danyelle R A Rios; Ana Paula Fernandes; Roberta C Figueiredo; Daniela A M Guimarães; Cláudia N Ferreira; Ana C Simões E Silva; Maria G Carvalho; Karina B Gomes; Luci Maria Sant' Ana Dusse
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

7.  ABO blood group influences transfusion and survival after cardiac surgery.

Authors:  Ian J Welsby; Barbara Phillips-Bute; Joseph P Mathew; Mark F Newman; Richard Becker; Sunil Rao; Carmelo A Milano; Mark Stafford-Smith
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

Review 8.  Preeclampsia and ABO blood groups: a systematic review and meta-analysis.

Authors:  Patricia Nessralla Alpoim; Melina de Barros Pinheiro; Daniela Rezende Garcia Junqueira; Leticia Gonçalves Freitas; Maria das Graças Carvalho; Ana Paula Salles Moura Fernandes; Flávia Komatsuzaki; Karina Braga Gomes; Luci Maria Sant'Ana Dusse
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

9.  Blood group O is a risk factor for delayed post-polypectomy bleeding.

Authors:  Hiroto Furuhashi; Akira Dobashi; Naoto Tamai; Nana Shimamoto; Masakuni Kobayashi; Shingo Ono; Yuko Hara; Hiroaki Matsui; Shunsuke Kamba; Hideka Horiuchi; Akio Koizumi; Tomohiko R Ohya; Masayuki Kato; Keiichi Ikeda; Hiroshi Arakawa; Kazuki Sumiyama
Journal:  Surg Endosc       Date:  2020-11-30       Impact factor: 4.584

10.  Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.

Authors:  Massimo Franchini; Franco Capra; Giovanni Targher; Martina Montagnana; Giuseppe Lippi
Journal:  Thromb J       Date:  2007-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.